Pediatric bronchial asthma is a heterogeneous disease with chronic airway inflammation as the main manifestation, which can develop at any age, generally starting before the age of 4-5 years. Most pediatric bronchial asthma has a history of respiratory symptoms of wheezing, shortness of breath, chest tightness and cough, accompanied by variable expiratory airflow limitation, and the symptoms and intensity of the airway can change over time. The treatment of pediatric bronchial asthma is as follows: 1. Acute exacerbation: to provide rapid and effective relief of symptoms, choose treatments that provide wheezing and anti-inflammatory therapy; 2. Chronic persistence and clinical remission: to prevent exacerbation of symptoms and prevent recurrence, such as avoiding exposure to asthma triggers, actively taking anti-inflammatory, reducing airway hyperresponsiveness, preventing airway remodeling, and good pediatric self-management. When treating pediatric bronchial asthma, we should focus on a combination of pharmacological and non-pharmacological treatments, and we should not neglect non-pharmacological treatments. For example, education on bronchial asthma prevention and control, avoidance of exposure to allergens and management of psychological problems of the affected children should be carried out. Parents should actively prevent and treat pediatric bronchial asthma, and the earlier the control and treatment of pediatric bronchial asthma, the better, so as not to delay the condition.